01 1Assia Chemical Industries Ltd.
02 1CADILA PHARMACEUTICALS LIMITED.
03 2CHONGQING KANGLE PHARMACEUTICAL CO. , LTD.
04 1CHONGQING KANGLE PHARMACEUTICAL CO. , LTD.
05 2Daito Co., Ltd.
06 1Daiwa Pharmaceutical Industries Co., Ltd.
07 1Ohara Pharmaceutical Co., Ltd.
08 1Ouchi Shinko Chemical Industry Co., Ltd.
09 2Pharmacostech CO. ,LTD
10 2Sanyo Chemical Research Institute Co., Ltd.
11 1Shin Poong Pharm. Co. , Ltd.
12 1YUHAN CORPORATION
01 10Cilostazol
02 1Cilostazol "Teva 2"
03 2Cilostazol (production only)
04 1Day stations cilostazol (production only)
05 2Japanese Pharmacopoeia cilostazol (production only)
01 3China
02 2Gabon
03 1India
04 1Israel
05 5Japan
06 4South Korea
Registration Number : 225MF10130
Registrant's Address : Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be'er Sheva 8412316, Israel
Initial Date of Registration : 2013-07-09
Latest Date of Registration : 2013-07-09
Cilostazol (for manufacturing only)
Registration Number : 218MF11022
Registrant's Address : Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, Gujarat, INDIA
Initial Date of Registration : 2006-12-28
Latest Date of Registration : 2018-12-11
Registration Number : 229MF10106
Registrant's Address : No. 4 HUAZHONG ROAD, CHONGQING (CHANGSHOU) CHEMICAL INDUSTRIAL PARK
Initial Date of Registration : 2017-06-21
Latest Date of Registration : 2017-06-21
Registration Number : 301MF10012
Registrant's Address : No. 4 HUAZHONG ROAD, CHONGQING (CHANGSHOU) CHEMICAL INDUSTRIAL PARK
Initial Date of Registration : 2019-05-31
Latest Date of Registration : 2019-05-31
Registration Number : 226MF10103
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2014-05-19
Latest Date of Registration : 2014-05-19
Japanese Pharmacopoeia Cilostazol (for manufacturing only)
Registration Number : 219MF10102
Registrant's Address : 121-15 Toriiino, Koka-cho, Koka City, Shiga Prefecture
Initial Date of Registration : 2007-03-23
Latest Date of Registration : 2019-03-29
Registration Number : 225MF10164
Registrant's Address : 47, Jeyakdanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Republic of Korea
Initial Date of Registration : 2013-08-14
Latest Date of Registration : 2013-08-14
Japanese Pharmacopoeia Cilostazol (for manufacturing only)
Registration Number : 227MF10119
Registrant's Address : 2-3-5 Shimookui, Toyama City, Toyama Prefecture
Initial Date of Registration : 2015-04-22
Latest Date of Registration : 2015-04-22
Registration Number : 230MF10009
Registrant's Address : 161, Yeoksam-ro, Gangnam-gu, Seoul, Korea
Initial Date of Registration : 2018-01-24
Latest Date of Registration : 2018-12-03
Registration Number : 225MF10205
Registrant's Address : 148-1 Tajii, Mihara-ku, Sakai City, Osaka Prefecture
Initial Date of Registration : 2013-11-11
Latest Date of Registration : 2013-11-11
A Cilostazol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilostazol, including repackagers and relabelers. The FDA regulates Cilostazol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilostazol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cilostazol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cilostazol supplier is an individual or a company that provides Cilostazol active pharmaceutical ingredient (API) or Cilostazol finished formulations upon request. The Cilostazol suppliers may include Cilostazol API manufacturers, exporters, distributors and traders.
click here to find a list of Cilostazol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cilostazol Drug Master File in Japan (Cilostazol JDMF) empowers Cilostazol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cilostazol JDMF during the approval evaluation for pharmaceutical products. At the time of Cilostazol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cilostazol suppliers with JDMF on PharmaCompass.
We have 10 companies offering Cilostazol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
